Skip to main content
Top
Published in: Insights into Imaging 4/2018

Open Access 01-08-2018 | Pictorial Review

Abdominal manifestations of IgG4-related disease: a pictorial review

Authors: Christopher Siew Wai Tang, Nishanth Sivarasan, Nyree Griffin

Published in: Insights into Imaging | Issue 4/2018

Login to get access

Abstract

In the last decade, autoimmune pancreatitis has become recognised as part of a wider spectrum of IgG4-related disease, typically associated with elevated serum IgG4 levels and demonstrating a response to corticosteroid therapy. Radiologically, there is imaging overlap with other benign and neoplastic conditions. This pictorial review discusses the intra-abdominal manifestations of this disease on cross-sectional imaging before and after steroid treatment and the main radiological features which help to distinguish it from other key differentials.

Teaching Points

Autoimmune pancreatitis is part of a spectrum of IgG4-related disease.
Diagnosis is based on raised serum IgG4, clinical, radiological and histopathological findings.
Cross-sectional imaging can demonstrate the typical findings of abdominal IgG4-related disease.
Cross-sectional imaging can be used to monitor response to corticosteroid treatment.
Literature
1.
go back to reference Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N (1995) Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 40:1561–1568CrossRefPubMed Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N (1995) Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 40:1561–1568CrossRefPubMed
2.
go back to reference Hamano H, Kawa S, Horiuchi A et al (2001) High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 344:732–738CrossRefPubMed Hamano H, Kawa S, Horiuchi A et al (2001) High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 344:732–738CrossRefPubMed
3.
go back to reference Kamisawa T, Funata N, Hayashi Y et al (2003) A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 38:982–984CrossRefPubMed Kamisawa T, Funata N, Hayashi Y et al (2003) A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 38:982–984CrossRefPubMed
5.
6.
7.
go back to reference Okazaki K, Uchida K (2015) Autoimmune pancreatitis: the past, present, and future. Pancreas 44:1006–1016CrossRefPubMed Okazaki K, Uchida K (2015) Autoimmune pancreatitis: the past, present, and future. Pancreas 44:1006–1016CrossRefPubMed
8.
go back to reference Deshpande V, Zen Y, Chan JK et al (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25:1181–1192CrossRefPubMed Deshpande V, Zen Y, Chan JK et al (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25:1181–1192CrossRefPubMed
9.
go back to reference Okazaki K, Umehara H (2012) Are classification criteria for IgG4-RD now possible? The concept of IgG4-related disease and proposal of comprehensive diagnostic criteria in Japan. Int J Rheumatol 2012:357071CrossRefPubMedPubMedCentral Okazaki K, Umehara H (2012) Are classification criteria for IgG4-RD now possible? The concept of IgG4-related disease and proposal of comprehensive diagnostic criteria in Japan. Int J Rheumatol 2012:357071CrossRefPubMedPubMedCentral
10.
go back to reference Stone JH, Khosroshahi A, Deshpande V et al (2012) Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum 64:3061–3067CrossRefPubMedPubMedCentral Stone JH, Khosroshahi A, Deshpande V et al (2012) Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum 64:3061–3067CrossRefPubMedPubMedCentral
11.
go back to reference Shimosegawa T, Chari ST, Frulloni L et al (2011) International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 40:352–358CrossRefPubMed Shimosegawa T, Chari ST, Frulloni L et al (2011) International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 40:352–358CrossRefPubMed
12.
go back to reference Kamisawa T, Imai M, Yui Chen P et al (2008) Strategy for differentiating autoimmune pancreatitis from pancreatic cancer. Pancreas 37:e62–e67CrossRefPubMed Kamisawa T, Imai M, Yui Chen P et al (2008) Strategy for differentiating autoimmune pancreatitis from pancreatic cancer. Pancreas 37:e62–e67CrossRefPubMed
13.
go back to reference Chari ST, Takahashi N, Levy MJ et al (2009) A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol Hepatol 7:1097–1103CrossRefPubMed Chari ST, Takahashi N, Levy MJ et al (2009) A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol Hepatol 7:1097–1103CrossRefPubMed
14.
go back to reference Zaheer A, Singh VK, Akshintala VS et al (2014) Differentiating autoimmune pancreatitis from pancreatic adenocarcinoma using dual-phase computed tomography. J Comput Assist Tomogr 38:146–152PubMedPubMedCentral Zaheer A, Singh VK, Akshintala VS et al (2014) Differentiating autoimmune pancreatitis from pancreatic adenocarcinoma using dual-phase computed tomography. J Comput Assist Tomogr 38:146–152PubMedPubMedCentral
15.
go back to reference Sun GF, Zuo CJ, Shao CW, Wang JH, Zhang J (2013) Focal autoimmune pancreatitis: radiological characteristics help to distinguish from pancreatic cancer. World J Gastroenterol 19:3634–3641CrossRefPubMedPubMedCentral Sun GF, Zuo CJ, Shao CW, Wang JH, Zhang J (2013) Focal autoimmune pancreatitis: radiological characteristics help to distinguish from pancreatic cancer. World J Gastroenterol 19:3634–3641CrossRefPubMedPubMedCentral
16.
go back to reference Suzuki K, Itoh S, Nagasaka T, Ogawa H, Ota T, Naganawa S (2010) CT findings in autoimmune pancreatitis: assessment using multiphase contrast-enhanced multisection CT. Clin Radiol 65:735–743CrossRefPubMed Suzuki K, Itoh S, Nagasaka T, Ogawa H, Ota T, Naganawa S (2010) CT findings in autoimmune pancreatitis: assessment using multiphase contrast-enhanced multisection CT. Clin Radiol 65:735–743CrossRefPubMed
17.
go back to reference Kawai Y, Suzuki K, Itoh S, Takada A, Mori Y, Naganawa S (2012) Autoimmune pancreatitis: assessment of the enhanced duct sign on multiphase contrast-enhanced computed tomography. Eur J Radiol 81:3055–3060CrossRefPubMed Kawai Y, Suzuki K, Itoh S, Takada A, Mori Y, Naganawa S (2012) Autoimmune pancreatitis: assessment of the enhanced duct sign on multiphase contrast-enhanced computed tomography. Eur J Radiol 81:3055–3060CrossRefPubMed
18.
go back to reference Furuhashi N, Suzuki K, Sakurai Y, Ikeda M, Kawai Y, Naganawa S (2015) Differentiation of focal-type autoimmune pancreatitis from pancreatic carcinoma: assessment by multiphase contrast-enhanced CT. Eur Radiol 25:1366–1374CrossRefPubMed Furuhashi N, Suzuki K, Sakurai Y, Ikeda M, Kawai Y, Naganawa S (2015) Differentiation of focal-type autoimmune pancreatitis from pancreatic carcinoma: assessment by multiphase contrast-enhanced CT. Eur Radiol 25:1366–1374CrossRefPubMed
19.
go back to reference Takahashi N, Fletcher JG, Hough DM et al (2009) Autoimmune pancreatitis: differentiation from pancreatic carcinoma and normal pancreas on the basis of enhancement characteristics at dual-phase CT. AJR Am J Roentgenol 193:479–484CrossRefPubMed Takahashi N, Fletcher JG, Hough DM et al (2009) Autoimmune pancreatitis: differentiation from pancreatic carcinoma and normal pancreas on the basis of enhancement characteristics at dual-phase CT. AJR Am J Roentgenol 193:479–484CrossRefPubMed
20.
go back to reference Choi SY, Kim SH, Kang TW, Song KD, Park HJ, Choi YH (2016) Differentiating mass-forming autoimmune pancreatitis from pancreatic ductal adenocarcinoma on the basis of contrast-enhanced MRI and DWI findings. AJR Am J Roentgenol 206:291–300CrossRefPubMed Choi SY, Kim SH, Kang TW, Song KD, Park HJ, Choi YH (2016) Differentiating mass-forming autoimmune pancreatitis from pancreatic ductal adenocarcinoma on the basis of contrast-enhanced MRI and DWI findings. AJR Am J Roentgenol 206:291–300CrossRefPubMed
21.
go back to reference Manfredi R, Graziani R, Cicero C et al (2008) Autoimmune pancreatitis: CT patterns and their changes after steroid treatment. Radiology 247:435–443CrossRefPubMed Manfredi R, Graziani R, Cicero C et al (2008) Autoimmune pancreatitis: CT patterns and their changes after steroid treatment. Radiology 247:435–443CrossRefPubMed
22.
go back to reference Sahani DV, Kalva SP, Farrell J et al (2004) Autoimmune pancreatitis: imaging features. Radiology 233:345–352CrossRefPubMed Sahani DV, Kalva SP, Farrell J et al (2004) Autoimmune pancreatitis: imaging features. Radiology 233:345–352CrossRefPubMed
23.
go back to reference Manfredi R, Frulloni L, Mantovani W, Bonatti M, Graziani R, Pozzi Mucelli R (2011) Autoimmune pancreatitis: pancreatic and extrapancreatic MR imaging-MR cholangiopancreatography findings at diagnosis, after steroid therapy, and at recurrence. Radiology 260:428–436CrossRefPubMed Manfredi R, Frulloni L, Mantovani W, Bonatti M, Graziani R, Pozzi Mucelli R (2011) Autoimmune pancreatitis: pancreatic and extrapancreatic MR imaging-MR cholangiopancreatography findings at diagnosis, after steroid therapy, and at recurrence. Radiology 260:428–436CrossRefPubMed
24.
go back to reference Carbognin G, Girardi V, Biasiutti C et al (2009) Autoimmune pancreatitis: imaging findings on contrast-enhanced MR, MRCP and dynamic secretin-enhanced MRCP. Radiol Med 114:1214–1231CrossRefPubMed Carbognin G, Girardi V, Biasiutti C et al (2009) Autoimmune pancreatitis: imaging findings on contrast-enhanced MR, MRCP and dynamic secretin-enhanced MRCP. Radiol Med 114:1214–1231CrossRefPubMed
25.
go back to reference Muhi A, Ichikawa T, Motosugi U et al (2012) Mass-forming autoimmune pancreatitis and pancreatic carcinoma: differential diagnosis on the basis of computed tomography and magnetic resonance cholangiopancreatography, and diffusion-weighted imaging findings. J Magn Reson Imaging 35:827–836CrossRefPubMed Muhi A, Ichikawa T, Motosugi U et al (2012) Mass-forming autoimmune pancreatitis and pancreatic carcinoma: differential diagnosis on the basis of computed tomography and magnetic resonance cholangiopancreatography, and diffusion-weighted imaging findings. J Magn Reson Imaging 35:827–836CrossRefPubMed
26.
go back to reference Negrelli R, Manfredi R, Pedrinolla B et al (2015) Pancreatic duct abnormalities in focal autoimmune pancreatitis: MR/MRCP imaging findings. Eur Radiol 25:359–367CrossRefPubMed Negrelli R, Manfredi R, Pedrinolla B et al (2015) Pancreatic duct abnormalities in focal autoimmune pancreatitis: MR/MRCP imaging findings. Eur Radiol 25:359–367CrossRefPubMed
27.
go back to reference Kamisawa T, Tu Y, Egawa N, Nakajima H, Tsuruta K, Okamoto A (2006) Involvement of pancreatic and bile ducts in autoimmune pancreatitis. World J Gastroenterol 12:612–614CrossRefPubMedPubMedCentral Kamisawa T, Tu Y, Egawa N, Nakajima H, Tsuruta K, Okamoto A (2006) Involvement of pancreatic and bile ducts in autoimmune pancreatitis. World J Gastroenterol 12:612–614CrossRefPubMedPubMedCentral
28.
go back to reference Sugumar A, Levy MJ, Kamisawa T et al (2011) Endoscopic retrograde pancreatography criteria to diagnose autoimmune pancreatitis: an international multicentre study. Gut 60:666–670CrossRefPubMed Sugumar A, Levy MJ, Kamisawa T et al (2011) Endoscopic retrograde pancreatography criteria to diagnose autoimmune pancreatitis: an international multicentre study. Gut 60:666–670CrossRefPubMed
29.
go back to reference Ichikawa T, Sou H, Araki T et al (2001) Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology 221:107–116CrossRefPubMed Ichikawa T, Sou H, Araki T et al (2001) Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology 221:107–116CrossRefPubMed
30.
go back to reference Kamisawa T, Takuma K, Anjiki H et al (2010) Differentiation of autoimmune pancreatitis from pancreatic cancer by diffusion-weighted MRI. Am J Gastroenterol 105:1870–1875CrossRefPubMed Kamisawa T, Takuma K, Anjiki H et al (2010) Differentiation of autoimmune pancreatitis from pancreatic cancer by diffusion-weighted MRI. Am J Gastroenterol 105:1870–1875CrossRefPubMed
31.
go back to reference Hur BY, Lee JM, Lee JE et al (2012) Magnetic resonance imaging findings of the mass-forming type of autoimmune pancreatitis: comparison with pancreatic adenocarcinoma. J Magn Reson Imaging 36:188–197CrossRefPubMed Hur BY, Lee JM, Lee JE et al (2012) Magnetic resonance imaging findings of the mass-forming type of autoimmune pancreatitis: comparison with pancreatic adenocarcinoma. J Magn Reson Imaging 36:188–197CrossRefPubMed
32.
go back to reference Ozaki Y, Oguchi K, Hamano H et al (2008) Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography. J Gastroenterol 43:144–151CrossRefPubMed Ozaki Y, Oguchi K, Hamano H et al (2008) Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography. J Gastroenterol 43:144–151CrossRefPubMed
33.
go back to reference Lee TY, Kim MH, Park DH et al (2009) Utility of 18F-FDG PET/CT for differentiation of autoimmune pancreatitis with atypical pancreatic imaging findings from pancreatic cancer. AJR Am J Roentgenol 193:343–348CrossRefPubMed Lee TY, Kim MH, Park DH et al (2009) Utility of 18F-FDG PET/CT for differentiation of autoimmune pancreatitis with atypical pancreatic imaging findings from pancreatic cancer. AJR Am J Roentgenol 193:343–348CrossRefPubMed
34.
35.
go back to reference Sahani DV, Sainani NI, Deshpande V, Shaikh MS, Frinkelberg DL, Fernandez-del Castillo C (2009) Autoimmune pancreatitis: disease evolution, staging, response assessment, and CT features that predict response to corticosteroid therapy. Radiology 250:118–129CrossRefPubMed Sahani DV, Sainani NI, Deshpande V, Shaikh MS, Frinkelberg DL, Fernandez-del Castillo C (2009) Autoimmune pancreatitis: disease evolution, staging, response assessment, and CT features that predict response to corticosteroid therapy. Radiology 250:118–129CrossRefPubMed
36.
go back to reference Matsubayashi H, Furukawa H, Maeda A et al (2009) Usefulness of positron emission tomography in the evaluation of distribution and activity of systemic lesions associated with autoimmune pancreatitis. Pancreatology 9:694–699CrossRefPubMed Matsubayashi H, Furukawa H, Maeda A et al (2009) Usefulness of positron emission tomography in the evaluation of distribution and activity of systemic lesions associated with autoimmune pancreatitis. Pancreatology 9:694–699CrossRefPubMed
37.
go back to reference Zhang L, Chari S, Smyrk TC et al (2011) Autoimmune pancreatitis (AIP) type 1 and type 2: an international consensus study on histopathologic diagnostic criteria. Pancreas 40:1172–1179CrossRefPubMed Zhang L, Chari S, Smyrk TC et al (2011) Autoimmune pancreatitis (AIP) type 1 and type 2: an international consensus study on histopathologic diagnostic criteria. Pancreas 40:1172–1179CrossRefPubMed
38.
go back to reference Nakazawa T, Ohara H, Sano H et al (2004) Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis. Gastrointest Endosc 60:937–944CrossRefPubMed Nakazawa T, Ohara H, Sano H et al (2004) Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis. Gastrointest Endosc 60:937–944CrossRefPubMed
39.
go back to reference Vlachou PA, Khalili K, Jang HJ, Fischer S, Hirschfield GM, Kim TK (2011) IgG4-related sclerosing disease: autoimmune pancreatitis and extrapancreatic manifestations. Radiographics 31:1379–1402CrossRefPubMed Vlachou PA, Khalili K, Jang HJ, Fischer S, Hirschfield GM, Kim TK (2011) IgG4-related sclerosing disease: autoimmune pancreatitis and extrapancreatic manifestations. Radiographics 31:1379–1402CrossRefPubMed
40.
go back to reference Kamisawa T, Egawa N, Nakajima H, Tsuruta K, Okamoto A (2005) Extrapancreatic lesions in autoimmune pancreatitis. J Clin Gastroenterol 39:904–907CrossRefPubMed Kamisawa T, Egawa N, Nakajima H, Tsuruta K, Okamoto A (2005) Extrapancreatic lesions in autoimmune pancreatitis. J Clin Gastroenterol 39:904–907CrossRefPubMed
41.
go back to reference Kawamoto S, Siegelman SS, Hruban RH, Fishman EK (2004) Lymphoplasmacytic sclerosing pancreatitis with obstructive jaundice: CT and pathology features. AJR Am J Roentgenol 183:915–921CrossRefPubMed Kawamoto S, Siegelman SS, Hruban RH, Fishman EK (2004) Lymphoplasmacytic sclerosing pancreatitis with obstructive jaundice: CT and pathology features. AJR Am J Roentgenol 183:915–921CrossRefPubMed
42.
go back to reference Kojima E, Kimura K, Noda Y, Kobayashi G, Itoh K, Fujita N (2003) Autoimmune pancreatitis and multiple bile duct strictures treated effectively with steroid. J Gastroenterol 38:603–607CrossRefPubMed Kojima E, Kimura K, Noda Y, Kobayashi G, Itoh K, Fujita N (2003) Autoimmune pancreatitis and multiple bile duct strictures treated effectively with steroid. J Gastroenterol 38:603–607CrossRefPubMed
43.
go back to reference Takahashi N, Kawashima A, Fletcher JG, Chari ST (2007) Renal involvement in patients with autoimmune pancreatitis: CT and MR imaging findings. Radiology 242:791–801CrossRefPubMed Takahashi N, Kawashima A, Fletcher JG, Chari ST (2007) Renal involvement in patients with autoimmune pancreatitis: CT and MR imaging findings. Radiology 242:791–801CrossRefPubMed
44.
go back to reference Triantopoulou C, Malachias G, Maniatis P, Anastopoulos J, Siafas I, Papailiou J (2010) Renal lesions associated with autoimmune pancreatitis: CT findings. Acta Radiol 51:702–707CrossRefPubMed Triantopoulou C, Malachias G, Maniatis P, Anastopoulos J, Siafas I, Papailiou J (2010) Renal lesions associated with autoimmune pancreatitis: CT findings. Acta Radiol 51:702–707CrossRefPubMed
45.
go back to reference Kim B, Kim JH, Byun JH et al (2014) IgG4-related kidney disease: MRI findings with emphasis on the usefulness of diffusion-weighted imaging. Eur J Radiol 83:1057–1062CrossRefPubMed Kim B, Kim JH, Byun JH et al (2014) IgG4-related kidney disease: MRI findings with emphasis on the usefulness of diffusion-weighted imaging. Eur J Radiol 83:1057–1062CrossRefPubMed
46.
go back to reference Sohn JH, Byun JH, Yoon SE et al (2008) Abdominal extrapancreatic lesions associated with autoimmune pancreatitis: radiological findings and changes after therapy. Eur J Radiol 67:497–507CrossRefPubMed Sohn JH, Byun JH, Yoon SE et al (2008) Abdominal extrapancreatic lesions associated with autoimmune pancreatitis: radiological findings and changes after therapy. Eur J Radiol 67:497–507CrossRefPubMed
47.
go back to reference Inoue D, Zen Y, Abo H et al (2011) Immunoglobulin G4-related periaortitis and periarteritis: CT findings in 17 patients. Radiology 261:625–633CrossRefPubMed Inoue D, Zen Y, Abo H et al (2011) Immunoglobulin G4-related periaortitis and periarteritis: CT findings in 17 patients. Radiology 261:625–633CrossRefPubMed
48.
go back to reference Zhang J, Chen H, Ma Y et al (2014) Characterizing IgG4-related disease with 18F-FDG PET/CT: a prospective cohort study. Eur J Nucl Med Mol Imaging 41:1624–1634CrossRefPubMedPubMedCentral Zhang J, Chen H, Ma Y et al (2014) Characterizing IgG4-related disease with 18F-FDG PET/CT: a prospective cohort study. Eur J Nucl Med Mol Imaging 41:1624–1634CrossRefPubMedPubMedCentral
49.
go back to reference Yabusaki S, Oyama-Manabe N, Manabe O et al (2017) Characteristics of immunoglobulin G4-related aortitis/periaortitis and periarteritis on fluorodeoxyglucose positron emission tomography/computed tomography co-registered with contrast-enhanced computed tomography. EJNMMI Res 7:20CrossRefPubMedPubMedCentral Yabusaki S, Oyama-Manabe N, Manabe O et al (2017) Characteristics of immunoglobulin G4-related aortitis/periaortitis and periarteritis on fluorodeoxyglucose positron emission tomography/computed tomography co-registered with contrast-enhanced computed tomography. EJNMMI Res 7:20CrossRefPubMedPubMedCentral
50.
go back to reference Bookhout CE, Rollins-Raval MA (2016) Immunoglobulin G4-related lymphadenopathy. Surg Pathol Clin 9:117–129CrossRefPubMed Bookhout CE, Rollins-Raval MA (2016) Immunoglobulin G4-related lymphadenopathy. Surg Pathol Clin 9:117–129CrossRefPubMed
51.
go back to reference Bulanov D, Arabadzhieva E, Bonev S et al (2016) A rare case of IgG4-related disease: a gastric mass, associated with regional lymphadenopathy. BMC Surg 16:37CrossRefPubMedPubMedCentral Bulanov D, Arabadzhieva E, Bonev S et al (2016) A rare case of IgG4-related disease: a gastric mass, associated with regional lymphadenopathy. BMC Surg 16:37CrossRefPubMedPubMedCentral
Metadata
Title
Abdominal manifestations of IgG4-related disease: a pictorial review
Authors
Christopher Siew Wai Tang
Nishanth Sivarasan
Nyree Griffin
Publication date
01-08-2018
Publisher
Springer Berlin Heidelberg
Published in
Insights into Imaging / Issue 4/2018
Electronic ISSN: 1869-4101
DOI
https://doi.org/10.1007/s13244-018-0618-1

Other articles of this Issue 4/2018

Insights into Imaging 4/2018 Go to the issue